Peter Schmid, Javier Cortes, Rebecca Dent, Lajos Pusztai, Heather McArthur, Sherko Kümmel, Jonas Bergh, Carsten Denkert, Yeon Hee Park, Rina Hui, Nadia Harbeck, Masato Takahashi, Michael Untch, Peter A Fasching, Fatima Cardoso, Jay Andersen, Debra Patt, Michael Danso, Marta Ferreira, Marie-Ange Mouret-Reynier, Seock-Ah Im, Jin-Hee Ahn, Maria Gion, Sally Baron-Hay, Jean-François Boileau, Yu Ding, Konstantinos Tryfonidis, Gursel Aktan, Vassiliki Karantza, Joyce O'Shaughnessy. N Engl J Med 2022
Times Cited: 111
Times Cited: 111
F Poggio, M Bruzzone, M Ceppi, N F Pondé, G La Valle, L Del Mastro, E de Azambuja, M Lambertini. Ann Oncol 2018
Times Cited: 196
Times Cited: 196
List of shared articles
Times cited
Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer.
Elisa Agostinetto, Agnese Losurdo, Guilherme Nader-Marta, Armando Santoro, Kevin Punie, Romualdo Barroso, Lazar Popovic, Cinzia Solinas, Marleen Kok, Evandro de Azambuja,[...]. Expert Opin Investig Drugs 2022
Elisa Agostinetto, Agnese Losurdo, Guilherme Nader-Marta, Armando Santoro, Kevin Punie, Romualdo Barroso, Lazar Popovic, Cinzia Solinas, Marleen Kok, Evandro de Azambuja,[...]. Expert Opin Investig Drugs 2022
Outcomes of non-metastatic triple negative breast cancers: Real-world data from a large Indian cohort.
Jyoti Bajpai, Lakhan Kashyap, Dilip Harindran Vallathol, Ankita Das, Maneesh Singh, Rima Pathak, Sushmita Rath, Anbarasan Sekar, Subham Mohanta, Asha Reddy,[...]. Breast 2022
Jyoti Bajpai, Lakhan Kashyap, Dilip Harindran Vallathol, Ankita Das, Maneesh Singh, Rima Pathak, Sushmita Rath, Anbarasan Sekar, Subham Mohanta, Asha Reddy,[...]. Breast 2022
The Evolving Role of Neoadjuvant Therapy for Operable Breast Cancer.
Laura M Spring, Yael Bar, Steven J Isakoff. J Natl Compr Canc Netw 2022
Laura M Spring, Yael Bar, Steven J Isakoff. J Natl Compr Canc Netw 2022
Immunotherapy for triple negative breast cancer: How can pathologic responses to experimental drugs in early-stage disease be enhanced?
Federica Giugliano, Carmine Valenza, Paolo Tarantino, Giuseppe Curigliano. Expert Opin Investig Drugs 2022
Federica Giugliano, Carmine Valenza, Paolo Tarantino, Giuseppe Curigliano. Expert Opin Investig Drugs 2022
Triple-Negative Breast Cancer: A Review of Current Curative Intent Therapies.
Isaiah MacDonald, Nancy A Nixon, Omar F Khan. Curr Oncol 2022
Isaiah MacDonald, Nancy A Nixon, Omar F Khan. Curr Oncol 2022
Optimal Choice of Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer: Clinical Insights.
Mairi W Lucas, Catherine M Kelly. Cancer Manag Res 2022
Mairi W Lucas, Catherine M Kelly. Cancer Manag Res 2022
Precision Breast Cancer Medicine: Early Stage Triple Negative Breast Cancer-A Review of Molecular Characterisation, Therapeutic Targets and Future Trends.
Karen Pinilla, Lynsey M Drewett, Rebecca Lucey, Jean E Abraham. Front Oncol 2022
Karen Pinilla, Lynsey M Drewett, Rebecca Lucey, Jean E Abraham. Front Oncol 2022
Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications.
Karama Asleh, Nazia Riaz, Torsten O Nielsen. J Exp Clin Cancer Res 2022
Karama Asleh, Nazia Riaz, Torsten O Nielsen. J Exp Clin Cancer Res 2022
Breast cancer: an up-to-date review and future perspectives.
Ruoxi Hong, Binghe Xu. Cancer Commun (Lond) 2022
Ruoxi Hong, Binghe Xu. Cancer Commun (Lond) 2022
Updated Neoadjuvant Treatment Landscape for Early Triple Negative Breast Cancer: Immunotherapy, Potential Predictive Biomarkers, and Novel Agents.
Giovanna Garufi, Luisa Carbognin, Francesco Schettini, Elia Seguí, Alba Di Leone, Antonio Franco, Ida Paris, Giovanni Scambia, Giampaolo Tortora, Alessandra Fabi. Cancers (Basel) 2022
Giovanna Garufi, Luisa Carbognin, Francesco Schettini, Elia Seguí, Alba Di Leone, Antonio Franco, Ida Paris, Giovanni Scambia, Giampaolo Tortora, Alessandra Fabi. Cancers (Basel) 2022
Genetic and functional homologous repair deficiency as biomarkers for platinum sensitivity in TNBC: A case report.
Diego Gomez-Puerto, Alba Llop-Guevara, Mara Cruellas, Sara Torres-Esquius, Javier De La Torre, Vicente Peg, Judith Balmaña, Isabel Pimentel. Front Oncol 2022
Diego Gomez-Puerto, Alba Llop-Guevara, Mara Cruellas, Sara Torres-Esquius, Javier De La Torre, Vicente Peg, Judith Balmaña, Isabel Pimentel. Front Oncol 2022
Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations.
William Jacot, Amélie Lusque, Cécile Vicier, Audrey Mailliez, Thibault de La Motte Rouge, Luc Cabel, Christelle Levy, Anne Patsouris, Isabelle Desmoulins, Lionel Uwer,[...]. Br J Cancer 2022
William Jacot, Amélie Lusque, Cécile Vicier, Audrey Mailliez, Thibault de La Motte Rouge, Luc Cabel, Christelle Levy, Anne Patsouris, Isabelle Desmoulins, Lionel Uwer,[...]. Br J Cancer 2022
Neoadjuvant therapy in triple-negative breast cancer: A systematic review and network meta-analysis.
Ying-Yi Lin, Hong-Fei Gao, Xin Yang, Teng Zhu, Xing-Xing Zheng, Fei Ji, Liu-Lu Zhang, Ci-Qiu Yang, Mei Yang, Jie-Qing Li,[...]. Breast 2022
Ying-Yi Lin, Hong-Fei Gao, Xin Yang, Teng Zhu, Xing-Xing Zheng, Fei Ji, Liu-Lu Zhang, Ci-Qiu Yang, Mei Yang, Jie-Qing Li,[...]. Breast 2022
Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer.
Elisa Agostinetto, Flavia Jacobs, Véronique Debien, Alex De Caluwé, Catalin-Florin Pop, Xavier Catteau, Philippe Aftimos, Evandro de Azambuja, Laurence Buisseret. Cancers (Basel) 2022
Elisa Agostinetto, Flavia Jacobs, Véronique Debien, Alex De Caluwé, Catalin-Florin Pop, Xavier Catteau, Philippe Aftimos, Evandro de Azambuja, Laurence Buisseret. Cancers (Basel) 2022